4HRH

Crystal Structure of p11-Annexin A2(N-terminal) Fusion Protein in Complex with SMARCA3 Peptide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.001 Å
  • R-Value Free: 0.263 
  • R-Value Work: 0.220 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

SMARCA3, a Chromatin-Remodeling Factor, Is Required for p11-Dependent Antidepressant Action.

Oh, Y.S.Gao, P.Lee, K.W.Ceglia, I.Seo, J.S.Zhang, X.Ahn, J.H.Chait, B.T.Patel, D.J.Kim, Y.Greengard, P.

(2013) Cell 152: 831-843

  • DOI: 10.1016/j.cell.2013.01.014
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • p11, through unknown mechanisms, is required for behavioral and cellular responses to selective serotonin reuptake inhibitors (SSRIs). We show that SMARCA3, a chromatin-remodeling factor, is a target for the p11/annexin A2 heterotetrameric complex. D ...

    p11, through unknown mechanisms, is required for behavioral and cellular responses to selective serotonin reuptake inhibitors (SSRIs). We show that SMARCA3, a chromatin-remodeling factor, is a target for the p11/annexin A2 heterotetrameric complex. Determination of the crystal structure indicates that SMARCA3 peptide binds to a hydrophobic pocket in the heterotetramer. Formation of this complex increases the DNA-binding affinity of SMARCA3 and its localization to the nuclear matrix fraction. In the dentate gyrus, both p11 and SMARCA3 are highly enriched in hilar mossy cells and basket cells. The SSRI fluoxetine induces expression of p11 in both cell types and increases the amount of the ternary complex of p11/annexin A2/SMARCA3. SSRI-induced neurogenesis and behavioral responses are abolished by constitutive knockout of SMARCA3. Our studies indicate a central role for a chromatin-remodeling factor in the SSRI/p11 signaling pathway and suggest an approach to the development of improved antidepressant therapies. PAPERCLIP:


    Organizational Affiliation

    Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Protein S100-A10, Annexin A2
A, B
117Homo sapiensMutation(s): 1 
Gene Names: S100A10 (ANX2LG, CAL1L, CLP11), ANXA2 (ANX2, ANX2L4, CAL1H, LPC2D)
Find proteins for P60903 (Homo sapiens)
Go to Gene View: S100A10
Go to UniProtKB:  P60903
Find proteins for P07355 (Homo sapiens)
Go to Gene View: ANXA2
Go to UniProtKB:  P07355
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Helicase-like transcription factor
C, D
14Homo sapiensMutation(s): 0 
Gene Names: HLTF (HIP116A, RNF80, SMARCA3, SNF2L3, ZBU1)
EC: 2.3.2.27, 3.6.4.-
Find proteins for Q14527 (Homo sapiens)
Go to Gene View: HLTF
Go to UniProtKB:  Q14527
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
SO4
Query on SO4

Download SDF File 
Download CCD File 
A, B
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.001 Å
  • R-Value Free: 0.263 
  • R-Value Work: 0.220 
  • Space Group: P 43 3 2
Unit Cell:
Length (Å)Angle (°)
a = 145.106α = 90.00
b = 145.106β = 90.00
c = 145.106γ = 90.00
Software Package:
Software NamePurpose
PHENIXrefinement
NECATdata collection
HKL-2000data reduction
PHASERphasing
HKL-2000data scaling

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2012-10-27 
  • Released Date: 2013-03-06 
  • Deposition Author(s): Gao, P., Patel, D.J.

Revision History 

  • Version 1.0: 2013-03-06
    Type: Initial release
  • Version 1.1: 2017-08-02
    Type: Refinement description, Source and taxonomy